UBS Group’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.4M | Sell |
163,718
-58,289
| -26% | -$5.13M | ﹤0.01% | 2136 |
|
|
2025
Q1 | $20.2M | Buy |
222,007
+204,864
| +1,195% | +$18.7M | ﹤0.01% | 1775 |
|
|
2024
Q4 | $1.48M | Buy |
17,143
+219
| +1% | +$18.9K | ﹤0.01% | 3946 |
|
|
2024
Q3 | $1.61M | Buy |
16,924
+1,840
| +12% | +$175K | ﹤0.01% | 3213 |
|
|
2024
Q2 | $1.38M | Sell |
15,084
-526
| -3% | -$48.1K | ﹤0.01% | 3137 |
|
|
2024
Q1 | $1.42M | Buy |
15,610
+2,067
| +15% | +$187K | ﹤0.01% | 3277 |
|
|
2023
Q4 | $1.1M | Buy |
13,543
+2,621
| +24% | +$213K | ﹤0.01% | 3366 |
|
|
2023
Q3 | $872K | Sell |
10,922
-1,516
| -12% | -$121K | ﹤0.01% | 3193 |
|
|
2023
Q2 | $980K | Sell |
12,438
-1,636
| -12% | -$129K | ﹤0.01% | 3326 |
|
|
2023
Q1 | $1.09M | Sell |
14,074
-398,355
| -97% | -$30.9M | ﹤0.01% | 3111 |
|
|
2022
Q4 | $32.1M | Sell |
412,429
-97,343
| -19% | -$7.57M | 0.01% | 771 |
|
|
2022
Q3 | $34.3M | Buy |
509,772
+15,436
| +3% | +$1.04M | 0.02% | 679 |
|
|
2022
Q2 | $38M | Buy |
494,336
+481,598
| +3,781% | +$37M | 0.02% | 672 |
|
|
2022
Q1 | $1.02M | Buy |
12,738
+6,981
| +121% | +$557K | ﹤0.01% | 3219 |
|
|
2021
Q4 | $443K | Sell |
5,757
-1,777
| -24% | -$137K | ﹤0.01% | 4072 |
|
|
2021
Q3 | $548K | Buy |
7,534
+1,294
| +21% | +$94.1K | ﹤0.01% | 3672 |
|
|
2021
Q2 | $456K | Sell |
6,240
-4,161
| -40% | -$304K | ﹤0.01% | 3812 |
|
|
2021
Q1 | $718K | Buy |
10,401
+4,069
| +64% | +$281K | ﹤0.01% | 3649 |
|
|
2020
Q4 | $421K | Sell |
6,332
-595
| -9% | -$39.6K | ﹤0.01% | 3795 |
|
|
2020
Q3 | $430K | Sell |
6,927
-699
| -9% | -$43.4K | ﹤0.01% | 3532 |
|
|
2020
Q2 | $475K | Sell |
7,626
-3,596
| -32% | -$224K | ﹤0.01% | 3428 |
|
|
2020
Q1 | $611K | Sell |
11,222
-1,266
| -10% | -$68.9K | ﹤0.01% | 3041 |
|
|
2019
Q4 | $802K | Buy |
12,488
+2,436
| +24% | +$156K | ﹤0.01% | 3517 |
|
|
2019
Q3 | $573K | Sell |
10,052
-1,767
| -15% | -$101K | ﹤0.01% | 3619 |
|
|
2019
Q2 | $693K | Sell |
11,819
-123
| -1% | -$7.21K | ﹤0.01% | 3308 |
|
|
2019
Q1 | $725K | Sell |
11,942
-1,499
| -11% | -$91K | ﹤0.01% | 3129 |
|
|
2018
Q4 | $736K | Sell |
13,441
-4,346
| -24% | -$238K | ﹤0.01% | 3229 |
|
|
2018
Q3 | $1.15M | Buy |
17,787
+953
| +6% | +$61.3K | ﹤0.01% | 3037 |
|
|
2018
Q2 | $993K | Buy |
16,834
+12
| +0.1% | +$708 | ﹤0.01% | 3069 |
|
|
2018
Q1 | $956K | Sell |
16,822
-80,204
| -83% | -$4.56M | ﹤0.01% | 3060 |
|
|
2017
Q4 | $5.75M | Sell |
97,026
-23,843
| -20% | -$1.41M | ﹤0.01% | 1733 |
|
|
2017
Q3 | $6.98M | Buy |
120,869
+14,931
| +14% | +$862K | ﹤0.01% | 1492 |
|
|
2017
Q2 | $6.26M | Buy |
105,938
+6,063
| +6% | +$358K | ﹤0.01% | 1519 |
|
|
2017
Q1 | $5.51M | Buy |
99,875
+1,423
| +1% | +$78.5K | ﹤0.01% | 1588 |
|
|
2016
Q4 | $5.17M | Buy |
98,452
+78,663
| +398% | +$4.13M | ﹤0.01% | 1567 |
|
|
2016
Q3 | $1.14M | Buy |
19,789
+3,518
| +22% | +$202K | ﹤0.01% | 2650 |
|
|
2016
Q2 | $954K | Sell |
16,271
-4,182
| -20% | -$245K | ﹤0.01% | 2738 |
|
|
2016
Q1 | $1.18M | Buy |
20,453
+3,245
| +19% | +$187K | ﹤0.01% | 2532 |
|
|
2015
Q4 | $1.12M | Sell |
17,208
-198
| -1% | -$12.9K | ﹤0.01% | 2614 |
|
|
2015
Q3 | $1.1M | Sell |
17,406
-4,626
| -21% | -$291K | ﹤0.01% | 2578 |
|
|
2015
Q2 | $1.56M | Buy |
22,032
+5,126
| +30% | +$363K | ﹤0.01% | 2496 |
|
|
2015
Q1 | $1.19M | Sell |
16,906
-6,716
| -28% | -$472K | ﹤0.01% | 2686 |
|
|
2014
Q4 | $1.52M | Buy |
+23,622
| New | +$1.52M | ﹤0.01% | 2441 |
|